Abreva and Earache - a phase IV clinical study of FDA data

Summary:

Earache is reported only by a few people who take Abreva.

The phase IV clinical study analyzes which people take Abreva and have Earache. It is created by eHealthMe based on reports of 15,949 people who have side effects while taking Abreva from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

15,949 people reported to have side effects when taking Abreva.
Among them, 1 person (0.01%) has Earache.


What is Abreva?

Abreva has active ingredients of docosanol. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 15,961 Abreva users for its effectiveness, alternative drugs and more.

What is Earache?

Earache (ear pain) is found to be associated with 629 drugs by eHealthMe.

Number of Abreva and Earache reports submitted per year:

Could Abreva cause Earache?

Gender of people who have Earache when taking Abreva *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Earache when taking Abreva *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common side effects people have besides Earache *:

  1. Pain In Face: 1 person, 100.00%
  2. Oral Pain: 1 person, 100.00%
  3. Face Oedema (swelling of face): 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Abreva and have Earache?

Check whether Earache is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Abreva:

Earache treatments and more:

COVID vaccines that are related to Earache:

How severe was Earache and when was it recovered:

Expand to all the drugs that have ingredients of docosanol:

All the drugs that are associated with Earache:

All the conditions that are associated with Earache:

How the study uses the data?

The study uses data from the FDA. It is based on docosanol (the active ingredients of Abreva) and Abreva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: